Skip to main content
. Author manuscript; available in PMC: 2014 Oct 16.
Published in final edited form as: Genet Med. 2008 Mar;10(3):161–166. doi: 10.1097/GIM.0b013e318163487d

Table 1.

Characteristics of BRCA mutation carriers eligible for prophylactic salpingo-oophorectomy (n = 88)

N (%)
Age at testing, median (range) 42 (23–71)
 Under 40 years 37 (42)
 40 or older 51 (58)
Mutation status
BRCA1 62 (70)
BRCA2 26 (30)
Ethnicity
 White 78 (89)
 Black 8 (9)
 Hispanic 2 (2)
Personal history of breast cancer
 Yes 52 (59)
 No 36 (41)
History of mastectomy
 No mastectomy 42 (48)
 Treatment mastectomya 26 (30)
 Prophylactic mastectomya 31 (35)
No. children
 None 17 (19)
 One child 14 (16)
 2–3 children 50 (57)
 4 or more children 7 (8)
No. FDRs and SDRs with breast cancer
 None 5 (6)
 1–2 44 (50)
 3–4 26 (30)
 5 or more 13 (15)
No. FDRs and SDRs with ovarian cancer
 None 35 (40)
 1 23 (26)
 2 20 (23)
 3 or more 10 (11)
a

Women could have had both a treatment and prophylactic mastectomy.

FDR, first degree relative; SDR, second degree relative.